Marker Therapeutics Total Current Liabilities 2011-2026 | MRKR

Annual Total Current Liabilities Marker Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
2.27 M	3.46 M	3.07 M	7.78 M	12.9 M	6.4 M	1.99 M	2.8 M	1.52 M	1.74 M	28 M	1.25 M	8.85 M	5.77 M	3.8 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
28 M	1.25 M	6.11 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Current Liabilities	Price	% 24h	Market Cap	Country
AgeX Therapeutics AGE	3.56 M	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	576 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	1.62 B	-	-	$ 40.3 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	1.77 M	-	-1.52 %	$ 24.7 M	USA
Enlivex Therapeutics Ltd. ENLV	9.02 M	$ 0.81	-3.11 %	$ 37 M	Israel
Exelixis EXEL	406 M	$ 46.21	-5.11 %	$ 12.5 B	USA
Athira Pharma ATHA	47.5 M	-	-	$ 269 M	USA
Fortress Biotech FBIO	49.7 M	$ 2.43	-4.71 %	$ 67.8 M	USA
Heron Therapeutics HRTX	96.1 M	$ 1.24	-5.73 %	$ 207 M	USA
Ionis Pharmaceuticals IONS	782 M	$ 75.53	-1.72 %	$ 12.1 B	USA
Институт стволовых клеток человека ISKJ	556 M	-	-	-	Russia
Kymera Therapeutics KYMR	83.2 M	$ 85.56	-0.81 %	$ 7.23 B	USA
Checkmate Pharmaceuticals CMPI	9.38 M	-	-	$ 231 M	USA
Ligand Pharmaceuticals Incorporated LGND	37.1 M	$ 212.11	-8.79 %	$ 3.88 B	USA
ACADIA Pharmaceuticals ACAD	395 M	$ 22.02	2.51 %	$ 3.65 B	USA
Mirum Pharmaceuticals MIRM	206 M	$ 100.27	-8.92 %	$ 5.03 B	USA
MannKind Corporation MNKD	171 M	$ 3.59	0.7 %	$ 1.1 B	USA
Advaxis ADXS	25 M	-	-9.65 %	$ 45.9 M	USA
Esperion Therapeutics ESPR	301 M	$ 3.15	-	$ 655 M	USA
Can-Fite BioPharma Ltd. CANF	2.73 M	$ 3.65	8.96 %	$ 6.01 M	Israel
Genprex GNPX	2.17 M	$ 0.88	-1.48 %	$ 821 K	USA
Aeglea BioTherapeutics AGLE	58.7 M	-	-	$ 1.01 B	USA
Matinas BioPharma Holdings MTNB	1.46 M	$ 0.65	-4.03 %	$ 3.56 M	USA
Applied Genetic Technologies Corporation AGTC	25.2 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	1.61 M	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	39.8 M	-	-	$ 3.67 B	USA
Aptose Biosciences APTO	9.31 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	6.29 M	-	-39.0 %	$ 4.57 M	USA
Akouos AKUS	16.8 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	45.3 M	-	-0.23 %	$ 916 M	USA
Allakos ALLK	36.6 M	-	-	$ 28.6 M	USA
AlloVir ALVR	9.71 M	-	4.14 %	$ 49.1 M	USA
Arcutis Biotherapeutics ARQT	130 M	$ 21.33	-11.75 %	$ 2.71 B	USA
Allena Pharmaceuticals ALNA	15.7 M	-	3.16 %	$ 1.9 M	USA
Ampio Pharmaceuticals AMPE	2.38 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	15.1 M	-	-	$ 10.1 M	USA
Alpine Immune Sciences ALPN	58 M	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	6.18 M	-	10.36 %	$ 9.8 M	USA
Applied Therapeutics APLT	71.2 M	-	-	$ 8.42 M	USA